465 related articles for article (PubMed ID: 16458148)
21. G-CSF after myocardial infarction accelerates angiogenesis and reduces fibrosis in swine.
Sato T; Suzuki H; Kusuyama T; Omori Y; Soda T; Tsunoda F; Shoji M; Iso Y; Koba S; Geshi E; Katagiri T; Kawachi K; Wakabayashi K; Takeyama Y
Int J Cardiol; 2008 Jul; 127(2):166-73. PubMed ID: 17692407
[TBL] [Abstract][Full Text] [Related]
22. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
23. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.
Iwanaga K; Takano H; Ohtsuka M; Hasegawa H; Zou Y; Qin Y; Odaka K; Hiroshima K; Tadokoro H; Komuro I
Biochem Biophys Res Commun; 2004 Dec; 325(4):1353-9. PubMed ID: 15555576
[TBL] [Abstract][Full Text] [Related]
24. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
[TBL] [Abstract][Full Text] [Related]
25. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
Guo Y; Liu C; He J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
[TBL] [Abstract][Full Text] [Related]
26. G-CSF does not improve systolic function in a rat model of acute myocardial infarction.
Werneck-de-Castro JP; Costa-E-Sousa RH; de Oliveira PF; Pinho-Ribeiro V; Mello DB; Peçanha R; Mattos E; Olivares EL; Maia AC; Mill JG; Dos Santos Goldenberg RC; Campos-de-Carvalho AC
Basic Res Cardiol; 2006 Nov; 101(6):494-501. PubMed ID: 16783485
[TBL] [Abstract][Full Text] [Related]
27. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.
Deng Z; Yang C; Deng H; Yang A; Geng T; Chen X; Ma A; Liu Z
Int J Cardiol; 2006 Oct; 113(1):92-6. PubMed ID: 16891014
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
Sun Y; Zhang JQ; Zhang J; Ramires FJ
J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
[TBL] [Abstract][Full Text] [Related]
30. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
[TBL] [Abstract][Full Text] [Related]
31. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
[TBL] [Abstract][Full Text] [Related]
32. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
33. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
[TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
35. Combined treatment with erythropoietin and granulocyte colony-stimulating factor enhances neovascularization and improves cardiac function after myocardial infarction.
Xue J; Du G; Shi J; Li Y; Yasutake M; Liu L; Li J; Kong Y; Wang S; Yun F; Li W
Chin Med J (Engl); 2014; 127(9):1677-83. PubMed ID: 24791874
[TBL] [Abstract][Full Text] [Related]
36. Phenytoin can accelerate the healing process after experimental myocardial infarction?
Zhou X; Li YM; Ji WJ; Jiang TM; Sun XN; Zhu Y; Shi R
Int J Cardiol; 2006 Feb; 107(1):21-9. PubMed ID: 15996772
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial.
Ellis SG; Penn MS; Bolwell B; Garcia M; Chacko M; Wang T; Brezina KJ; McConnell G; Topol EJ
Am Heart J; 2006 Dec; 152(6):1051.e9-14. PubMed ID: 17161051
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.
Morimoto H; Takahashi M; Shiba Y; Izawa A; Ise H; Hongo M; Hatake K; Motoyoshi K; Ikeda U
Am J Pathol; 2007 Sep; 171(3):755-66. PubMed ID: 17640962
[TBL] [Abstract][Full Text] [Related]
40. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis.
Deindl E; Zaruba MM; Brunner S; Huber B; Mehl U; Assmann G; Hoefer IE; Mueller-Hoecker J; Franz WM
FASEB J; 2006 May; 20(7):956-8. PubMed ID: 16571777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
